<--- Back to Details
First PageDocument Content
Angiology / Hematology / Transient ischemic attack / Thrombosis / Ischemia / Atherosclerosis / Aneurysm / Embolism / Thrombus / Medicine / Circulatory system / Stroke
Date: 2014-03-15 18:50:38
Angiology
Hematology
Transient ischemic attack
Thrombosis
Ischemia
Atherosclerosis
Aneurysm
Embolism
Thrombus
Medicine
Circulatory system
Stroke

Middle cerebral artery Anterior cerebral artery Posterior cerebral

Add to Reading List

Source URL: www.eldercareresources.ca

Download Document from Source Website

File Size: 599,57 KB

Share Document on Facebook

Similar Documents

5.5

5.5" MEDICATION GUIDE WARFARIN Warfarin Sodium Tablets, USP Crystalline Who should not take WARFARIN?

DocID: 1qNvd - View Document

1st Annual  Hematology Symposium Saturday, April 30, 2016 Disney’s Grand Californian Hotel® & Spa at the Disneyland® Resort in Anaheim, Calif.

1st Annual Hematology Symposium Saturday, April 30, 2016 Disney’s Grand Californian Hotel® & Spa at the Disneyland® Resort in Anaheim, Calif.

DocID: 1qdh0 - View Document

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

DocID: 1lXGG - View Document

Daiichi Sankyo Signs Agreement with Translational Sciences, Inc. to Develop and Commercialize the First-In-Class Thrombus Dissolving Agent, TS23 TOKYO, Japan (September 15, 2015) – Daiichi Sankyo Company, Ltd. (hereaft

Daiichi Sankyo Signs Agreement with Translational Sciences, Inc. to Develop and Commercialize the First-In-Class Thrombus Dissolving Agent, TS23 TOKYO, Japan (September 15, 2015) – Daiichi Sankyo Company, Ltd. (hereaft

DocID: 1lSzK - View Document

New Zealand Consumer Medicine Information  METALYSE® Tenecteplase  What is in this leaflet

New Zealand Consumer Medicine Information METALYSE® Tenecteplase What is in this leaflet

DocID: 1g5wH - View Document